341 related articles for article (PubMed ID: 22328582)
21. Characterization of the metabolism of sibiricaxanthone F and its aglycone in vitro by high performance liquid chromatography coupled with Q-trap mass spectrometry.
Song Y; Yang X; Jiang Y; Tu P
J Pharm Biomed Anal; 2012 Nov; 70():700-7. PubMed ID: 22819207
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous determination of MK-0767 and seven metabolites in rat urine using liquid chromatography/tandem mass spectrometry.
Shen Z; Kochansky C; Bakhtiar R; Franklin RB; Vincent SH
Rapid Commun Mass Spectrom; 2004; 18(18):2113-20. PubMed ID: 15317046
[TBL] [Abstract][Full Text] [Related]
23. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
[TBL] [Abstract][Full Text] [Related]
24. In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes.
Aprile S; Del Grosso E; Tron GC; Grosa G
Drug Metab Dispos; 2007 Dec; 35(12):2252-61. PubMed ID: 17890446
[TBL] [Abstract][Full Text] [Related]
25. Absorption, metabolism and excretion of [(14)C]mirabegron (YM178), a potent and selective β(3)-adrenoceptor agonist, after oral administration to healthy male volunteers.
Takusagawa S; van Lier JJ; Suzuki K; Nagata M; Meijer J; Krauwinkel W; Schaddelee M; Sekiguchi M; Miyashita A; Iwatsubo T; van Gelderen M; Usui T
Drug Metab Dispos; 2012 Apr; 40(4):815-24. PubMed ID: 22269146
[TBL] [Abstract][Full Text] [Related]
26. Biotransformation of [14C]dasatinib: in vitro studies in rat, monkey, and human and disposition after administration to rats and monkeys.
Christopher LJ; Cui D; Li W; Barros A; Arora VK; Zhang H; Wang L; Zhang D; Manning JA; He K; Fletcher AM; Ogan M; Lago M; Bonacorsi SJ; Humphreys WG; Iyer RA
Drug Metab Dispos; 2008 Jul; 36(7):1341-56. PubMed ID: 18420785
[TBL] [Abstract][Full Text] [Related]
27. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
[TBL] [Abstract][Full Text] [Related]
28. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs.
Prakash C; Cui D; Potchoiba MJ; Butler T
Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205
[TBL] [Abstract][Full Text] [Related]
29. Identification of circulatory and excretory metabolites of meisoindigo in rat plasma, urine and feces by high-performance liquid chromatography coupled with positive electrospray ionization tandem mass spectrometry.
Huang M; Lee YS; Ho PC
Rapid Commun Mass Spectrom; 2010 Mar; 24(6):729-41. PubMed ID: 20169560
[TBL] [Abstract][Full Text] [Related]
30. Metabolism and excretion of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazine-1-sulfonyl]-2-propoxyphenyl}-7-propyl-3,5-dihydropyrrolo[3,2-d]-pyrimidin-4-one (SK3530) in rats.
Lee J; Yoo HH; Rhim KJ; Sohn DR; Kim DH
Rapid Commun Mass Spectrom; 2007; 21(7):1139-49. PubMed ID: 17318927
[TBL] [Abstract][Full Text] [Related]
31. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
Lang D; Freudenberger C; Weinz C
Drug Metab Dispos; 2009 May; 37(5):1046-55. PubMed ID: 19196846
[TBL] [Abstract][Full Text] [Related]
32. Metabolism, pharmacokinetics, and excretion of the 5-hydroxytryptamine1b receptor antagonist elzasonan in humans.
Kamel A; Obach RS; Colizza K; Wang W; O'Connell TN; Coelho RV; Kelley RM; Schildknegt K
Drug Metab Dispos; 2010 Nov; 38(11):1984-99. PubMed ID: 20668248
[TBL] [Abstract][Full Text] [Related]
33. Disposition and metabolism of radiolabeled casopitant in humans.
Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
[TBL] [Abstract][Full Text] [Related]
34. Excretion, metabolism, and pharmacokinetics of CP-945,598, a selective cannabinoid receptor antagonist, in rats, mice, and dogs.
Miao Z; Scott DO; Griffith DA; Day R; Prakash C
Drug Metab Dispos; 2011 Dec; 39(12):2191-208. PubMed ID: 21875952
[TBL] [Abstract][Full Text] [Related]
35. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans.
Weinz C; Schwarz T; Kubitza D; Mueck W; Lang D
Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845
[TBL] [Abstract][Full Text] [Related]
36. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
37. Structural elucidation of hydroxylated metabolites of the isoflavan equol by gas chromatography-mass spectrometry and high-performance liquid chromatography-mass spectrometry.
Rüfer CE; Glatt H; Kulling SE
Drug Metab Dispos; 2006 Jan; 34(1):51-60. PubMed ID: 16199471
[TBL] [Abstract][Full Text] [Related]
38. Toxicokinetics and biotransformation of 3-(4-methylbenzylidene)camphor in rats after oral administration.
Völkel W; Colnot T; Schauer UM; Broschard TH; Dekant W
Toxicol Appl Pharmacol; 2006 Oct; 216(2):331-8. PubMed ID: 16806338
[TBL] [Abstract][Full Text] [Related]
39. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
[TBL] [Abstract][Full Text] [Related]
40. Disposition and metabolism of finasteride in dogs.
Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]